Oral Gallium Maltolate for Recurrent Glioblastoma

by palligoelme@gmail.com | Apr 7, 2026 | Clinical Trials

​ Conditions: Glioblastoma Interventions: Drug: Gallium Maltolate; Procedure: Surgical Intervention Sponsors: Medical College of Wisconsin Not yet recruiting Conditions: Glioblastoma Interventions: Drug: Gallium Maltolate; Procedure: Surgical Intervention Sponsors:...

MRI-Assisted Guidance for Non-Essential Tissue Sampling

by palligoelme@gmail.com | Apr 7, 2026 | Clinical Trials

​ Conditions: PSA Progression; PSA Interventions: Procedure: Paired Prostate Biopsy Cohort (TB + SB) Sponsors: Shanghai East Hospital Not yet recruiting Conditions: PSA Progression; PSA Interventions: Procedure: Paired Prostate Biopsy Cohort (TB + SB) Sponsors:...

Galenos 2 Immunonutrition in Head and Neck, Lung, and Rectal Cancer Patients

by palligoelme@gmail.com | Apr 7, 2026 | Clinical Trials

​ Conditions: Head and Neck Squamous Cell Carcinoma; Locally Advanced Rectal Cancer; Lung Cancer Interventions: Dietary Supplement: Galenic Immunonutrition Formula Sponsors: Fondazione del Piemonte per l’Oncologia Recruiting Conditions: Head and Neck Squamous...

Effectiveness of Intensive Tutoring vs. Flexible Self-Learning on Digital Health Literacy and Self-Efficacy for “My Health Bank” App Use Among Adults Over 50: A Randomized Controlled Trial Using AI-Co-Created Materials

by palligoelme@gmail.com | Apr 7, 2026 | Clinical Trials

​ Conditions: Digital Health Literacy; Healthy Aging Interventions: Behavioral: AI-Collaborative eHealth Education Sponsors: Tri-Service General Hospital Recruiting Conditions: Digital Health Literacy; Healthy Aging Interventions: Behavioral: AI-Collaborative eHealth...

Comparison of Safety and Patients-Reported Outcomes Between Single-Port Endoscopic and Conventional Nipple-Sparing Mastectomy With Immediate Implant Reconstruction

by palligoelme@gmail.com | Apr 7, 2026 | Clinical Trials

​ Conditions: Breast Cancer; Breast Reconstruction Sponsors: Xijing Hospital Completed Conditions: Breast Cancer; Breast Reconstruction Sponsors: Xijing Hospital Completed 

FULIRI Plus Targeted Therapy for First-line Conversion Therapy of Colorectal Cancer Liver Metastases.

by palligoelme@gmail.com | Apr 7, 2026 | Clinical Trials

​ Conditions: Colo-rectal Cancer Interventions: Drug: FULIRI combination targeted therapy Sponsors: Zhongnan Hospital Not yet recruiting Conditions: Colo-rectal Cancer Interventions: Drug: FULIRI combination targeted therapy Sponsors: Zhongnan Hospital Not yet...